BNTX Annual Revenue
$4.13 B
-$14.12 B-77.35%
31 December 2023
Summary:
As of January 22, 2025, BNTX annual revenue is $4.13 billion, with the most recent change of -$14.12 billion (-77.35%) on December 31, 2023. During the last 3 years, it has risen by +$3.58 billion (+650.63%). BNTX annual revenue is now -81.59% below its all-time high of $22.45 billion, reached on December 31, 2021.BNTX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BNTX Quarterly Revenue
$1.37 B
+$1.23 B+887.92%
01 September 2024
Summary:
As of January 22, 2025, BNTX quarterly revenue is $1.37 billion, with the most recent change of +$1.23 billion (+887.92%) on September 1, 2024. Over the past year, it has dropped by -$223.70 million (-14.05%). BNTX quarterly revenue is now -80.93% below its all-time high of $7.18 billion, reached on September 30, 2021.BNTX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BNTX TTM Revenue
$3.30 B
+$394.25 M+13.55%
01 September 2024
Summary:
As of January 22, 2025, BNTX TTM revenue is $3.30 billion, with the most recent change of +$394.25 million (+13.55%) on September 1, 2024. Over the past year, it has dropped by -$817.81 million (-19.84%). BNTX TTM revenue is now -87.79% below its all-time high of $27.06 billion, reached on March 31, 2022.BNTX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BNTX Revenue Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -77.3% | -14.1% | -19.8% |
3 y3 years | +650.6% | -80.9% | -87.8% |
5 y5 years | +2644.6% | +4195.7% | +1672.3% |
BNTX Revenue High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -81.6% | at low | -80.9% | +887.9% | -87.8% | +13.6% |
5 y | 5-year | -81.6% | +3300.7% | -80.9% | +4378.6% | -87.8% | +2618.3% |
alltime | all time | -81.6% | +5826.7% | -80.9% | +5672.4% | -87.8% | >+9999.0% |
BioNTech SE Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $1.37 B(+887.9%) | $3.30 B(+13.5%) |
June 2024 | - | $138.58 M(-32.0%) | $2.91 B(-1.5%) |
Mar 2024 | - | $203.77 M(-87.2%) | $2.95 B(-28.3%) |
Dec 2023 | $4.13 B(-77.4%) | $1.59 B(+63.4%) | $4.12 B(-40.3%) |
Sept 2023 | - | $974.79 M(+433.1%) | $6.90 B(-26.7%) |
June 2023 | - | $182.87 M(-86.7%) | $9.42 B(-25.5%) |
Mar 2023 | - | $1.37 B(-68.6%) | $12.64 B(-31.4%) |
Dec 2022 | $18.26 B(-18.7%) | $4.37 B(+25.5%) | $18.42 B(-9.6%) |
Sept 2022 | - | $3.49 B(+2.4%) | $20.37 B(-15.3%) |
June 2022 | - | $3.40 B(-52.4%) | $24.06 B(-11.1%) |
Mar 2022 | - | $7.15 B(+13.0%) | $27.06 B(+20.9%) |
Dec 2021 | $22.45 B | $6.33 B(-11.8%) | $22.37 B(+36.0%) |
Sept 2021 | - | $7.18 B(+12.2%) | $16.46 B(+75.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2021 | - | $6.40 B(+159.2%) | $9.36 B(+211.4%) |
Mar 2021 | - | $2.47 B(+499.4%) | $3.01 B(+429.8%) |
Dec 2020 | $550.80 M(+353.0%) | $411.82 M(+421.7%) | $567.25 M(+204.3%) |
Sept 2020 | - | $78.93 M(+71.9%) | $186.43 M(+33.8%) |
June 2020 | - | $45.92 M(+50.2%) | $139.37 M(+13.9%) |
Mar 2020 | - | $30.57 M(-1.4%) | $122.41 M(+0.7%) |
Dec 2019 | $121.58 M(-19.3%) | $31.00 M(-2.7%) | $121.55 M(-25.6%) |
Sept 2019 | - | $31.87 M(+10.0%) | $163.31 M(+5.3%) |
June 2019 | - | $28.97 M(-2.5%) | $155.16 M(+23.0%) |
Mar 2019 | - | $29.71 M(-59.2%) | $126.19 M(+30.8%) |
Dec 2018 | $150.64 M(+115.9%) | $72.77 M(+206.8%) | $96.49 M(+306.8%) |
Sept 2018 | - | $23.72 M | $23.72 M |
Dec 2017 | $69.76 M | - | - |
FAQ
- What is BioNTech SE annual revenue?
- What is the all time high annual revenue for BioNTech SE?
- What is BioNTech SE annual revenue year-on-year change?
- What is BioNTech SE quarterly revenue?
- What is the all time high quarterly revenue for BioNTech SE?
- What is BioNTech SE quarterly revenue year-on-year change?
- What is BioNTech SE TTM revenue?
- What is the all time high TTM revenue for BioNTech SE?
- What is BioNTech SE TTM revenue year-on-year change?
What is BioNTech SE annual revenue?
The current annual revenue of BNTX is $4.13 B
What is the all time high annual revenue for BioNTech SE?
BioNTech SE all-time high annual revenue is $22.45 B
What is BioNTech SE annual revenue year-on-year change?
Over the past year, BNTX annual revenue has changed by -$14.12 B (-77.35%)
What is BioNTech SE quarterly revenue?
The current quarterly revenue of BNTX is $1.37 B
What is the all time high quarterly revenue for BioNTech SE?
BioNTech SE all-time high quarterly revenue is $7.18 B
What is BioNTech SE quarterly revenue year-on-year change?
Over the past year, BNTX quarterly revenue has changed by -$223.70 M (-14.05%)
What is BioNTech SE TTM revenue?
The current TTM revenue of BNTX is $3.30 B
What is the all time high TTM revenue for BioNTech SE?
BioNTech SE all-time high TTM revenue is $27.06 B
What is BioNTech SE TTM revenue year-on-year change?
Over the past year, BNTX TTM revenue has changed by -$817.81 M (-19.84%)